Badgley, Phelps & Bell’s Novartis NVS Stock Holding History

Badgley, Phelps & Bell’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,341	Closed	-$221K	–	225
2020 Q4	$221K	Sell	2,341 -30	-1%	-$2.62K	0.01%	202
2020 Q3	$206K	Sell	2,371 -2,150	-48%	-$186K	0.01%	199
2020 Q2	$395K	Sell	4,521 -500	-10%	-$43.2K	0.02%	156
2020 Q1	$414K	Buy	5,021 +35	+0.7%	+$3.12K	0.03%	138
2019 Q4	$472K	Sell	4,986 -361	-7%	-$32.4K	0.02%	148
2019 Q3	$465K	Buy	5,347 +1,000	+23%	+$89.8K	0.03%	144
2019 Q2	$397K	Sell	4,347 -586	-12%	-$49.6K	0.02%	152
2019 Q1	$425K	Hold	4,933	–	–	0.03%	153
2018 Q4	$379K	Sell	4,933 -2	-0%	-$156	0.03%	149
2018 Q3	$381K	Sell	4,935 -142	-3%	-$10.5K	0.02%	157
2018 Q2	$344K	Sell	5,077 -312	-6%	-$21.5K	0.02%	155
2018 Q1	$390K	Sell	5,389 -202	-4%	-$15.4K	0.03%	152
2017 Q4	$421K	Buy	+5,591	New	+$422K	0.03%	150
2016 Q1	–	Sell	-3,119	Closed	-$240K	–	154
2015 Q4	$240K	Buy	3,119 +609	+24%	+$48.4K	0.02%	132
2015 Q3	$207K	Buy	+2,510	New	+$223K	0.02%	133

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Badgley, Phelps & Bell's NVS Position: Q1 2021 in Review

Badgley, Phelps & Bell sold out of Novartis (NVS) in Q1 2021, closing a stake of 2,341 shares — an estimated $221K sold.

Badgley, Phelps & Bell first reported a position in NVS in Q3 2015 and held it in 15 quarters. The position peaked at $472K in Q4 2019. 1,136 funds tracked by Wall St. Rank hold NVS as of Q1 2021.

Badgley, Phelps & Bell reported no remaining Novartis position as of Q1 2021 after selling out during the quarter.
Badgley, Phelps & Bell sold 2,341 Novartis shares in Q1 2021, an estimated $221K.
Badgley, Phelps & Bell first reported a position in Novartis in Q3 2015 and held it in 15 quarters.
Badgley, Phelps & Bell's Novartis position peaked at $472K in Q4 2019.
1,136 funds tracked by Wall St. Rank held Novartis as of Q1 2021.

Based on Badgley, Phelps & Bell's 13F filing for Q1 2021, filed 28 Apr 2021.